This page contains a Flash digital edition of a book.
Special Feature


the subject and the baseline tym‐ panic temperature was recorded.


3. Temperature measurements were recorded every two (2) min‐ utes.


4. The Extreme Cooling Element (EXCEL) was exchanged at 20 minutes.


5. Final temperature measurement was recorded at 26 minutes.


All subjects were healthy adult males and females without significant prior medical history and all were fully clothed. Sweaters and fleece garments were allowed to remain for personal comfort.


RESULTS


Nine subjects were tested. Subjects were cooled for 26 minutes. There were no adverse events noted. Temperature reduction was shown to be between 0.7 to 1.3 degrees Celsius within 26 minutes.


Around minute 12, all subjects showed some signs of cooling compen‐ sation to naturally generate heat (i.e. abdominal muscle twitching and feet rubbing), but only one manifested


OBSERVATIONS Patient Number/Age/Gender


#0001 18 y/o female 55 KGs


#0002 20 y/o male 111 KGs


#0006 47 y/o female 87.2 KGs


#0009 54 y/o female 67.2 KGs


overt shivering. Subjects reported cold sensation but very little discomfort. The skin of the neck to which the EXCEL was applied was carefully examined at the conclusion of the study and again after 24 hours. There was no evidence of any skin irritation.


SUMMARY


Upon conclusion of the pilot trial, the SCCC proved to effectively reduce brain temperature 0.7 to 1.3 degrees Celsius within 26 minutes. When used for the pulseless and apneic patient the SCCC will be able to rapidly and effec‐ tively induce mild cerebral hypother‐ mia. The ease of use of the SCCC insures wide spread adoption allowing EMS and hospital personnel to better care for the patient.


The SCCC is a noninvasive, easy to use, and reliable method proven effec‐ tive in reducing brain temperature up to 1.3 degrees Celsius in less than 30 minutes. Mild cerebral hypothermia may be maintained indefinitely with the use of the SCCC by refreshing the extreme cooling element (EXCEL) every 20 minutes. The SCCC may have wide spread applications in the treat‐ ment of cardiac arrest, stroke, neuro‐ genic fever, and traumatic brain injury.


Observations


SCCC Life Core system applied, 22c ambi- ent temperature 36.7c beginning tympan- ic temperature


8min 36.0c, 26 min 35.0c


SCCC Life Core system applied 22c ambi- ent temperature. 37.3 beginning tympan- ic temperature


8 min 37.2c, 24 min 36.2c


SCCC Life Core system applied, 23c ambi- ent beginning tympanic 37.3c, ending tympanic 36.0c


SCCC Life Core system applied, 22c ambi- ent temperature, 37.3 beginning tympan- ic, and 36.2 ending. ***Test stopped at 16 minutes for shivering


BACKGROUND


Aqeel A. Sandhu, MD, FACS, founder of Life Core Technologies, LLC and inventor of the SCCC is also the Director of Cardiovascular Surgery at Mercy Medical Center in Canton, Ohio. He began development of the SCCC when he discovered during his research in large animal models that selective brain cooling was feasible and neurprotective without adverse seque‐ lae. Knowing the importance of ultra‐ early cooling and the need for a simple to use device the Sandhu Cerebral Cooling Collar (SCCC) was born.


DISCLAIMER


The information contained in this document is the proprietary and exclu‐ sive property of Life Core Technologies LLC except as otherwise indicated. No part of this document, in whole or in part, may be reproduced, stored, trans‐ mitted, or used for design purposes without the prior written permission of Life Core Technologies LLC. The infor‐ mation contained in this document is subject to change without notice. The information in this document is provid‐ ed for informational purposes only.


PRIVACY INFORMATION


This document may contain informa‐ tion of a sensitive nature. If copies of the data from the pilot study are required please contact Patrick S. O’Boyle or send a request to patrick.oboyle@wakegov.com EMS


CONTACT US


Life Core Technologies LLC Tel: 877‐528‐2888 Fax: 877‐528‐2990


Email: info@lifecoretech.com


34 EMS PRO Magazine


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52